Portable hyperbaric therapy that simulates descent for severe altitude illness when real descent isn't possible
High-altitude pulmonary edema (HAPE) and high-altitude cerebral edema (HACE) are the two life-threatening forms of altitude illness. Both have one definitive first-line treatment — immediate descent. But descent is not always available: whiteout storms, avalanche terrain, darkness, and exhausted teammates can make moving a critically ill climber more dangerous than staying put. The Gamow bag was invented to fill exactly this gap.
HAPE presents with progressive dyspnea at rest, a dry cough that becomes productive of pink frothy sputum, crackles or wheezes audible without a stethoscope, and resting oxygen saturation far below what is normal for the altitude. It is a form of non-cardiogenic pulmonary edema driven by exaggerated hypoxic pulmonary vasoconstriction — uneven vessel constriction raises capillary pressure in some lung segments and forces fluid into the alveoli.
HACE presents with headache unresponsive to analgesics, truncal ataxia (a climber who cannot walk a straight line heel-to-toe), confusion, and in severe cases, decreasing consciousness and coma. It reflects vasogenic cerebral edema, likely from cerebral vasodilation and blood-brain-barrier leakage under hypoxic stress. HACE can progress from mild confusion to unresponsiveness within hours.
Both conditions are graded using the Lake Louise Score, and both share the same emergency algorithm: descend, give supplemental oxygen if available, and treat pharmacologically — but descent is the only intervention proven to reliably reverse the underlying process.
Case fatality for untreated HACE approaches 100% once coma develops. Every hour of delay before descent (or an effective substitute) measurably worsens outcome — which is exactly the window a Gamow bag is designed to buy.
Guides and rescue teams do not choose to delay descent lightly — but several real field constraints routinely make it impossible or lethally risky in the short term:
• Whiteout storms and high wind: visibility can drop to a few meters, and wind chill on exposed ridgelines can cause fatal hypothermia or frostbite to rescuers within minutes • Darkness on technical terrain: down-climbing icefalls, crevassed glaciers, or fixed-line headwalls at night dramatically raises fall and crevasse-fall risk for both patient and rescuers • Avalanche hazard: descending during or immediately after heavy snowfall can trigger slab avalanches on the very route needed to get down • Physical inability to move the patient: a single unconscious HACE patient may require 4–6 rescuers to lower on a technical route — a team of two or three simply cannot safely execute it • Helicopter unavailability: high-altitude rescue helicopters have hard ceiling limits (roughly 6000–7000m depending on aircraft and air density) and cannot fly in poor weather at all
In any of these situations, the team is medically obligated to act immediately — but physically unable to descend. This is precisely the scenario a portable hyperbaric bag was designed to bridge.
If the problem is insufficient inspired oxygen pressure at altitude, and the treatment is descending to where the air is thicker, then an alternative is to bring "thicker air" to the patient instead of bringing the patient down to it. A sealed, pressurizable enclosure can raise the ambient pressure around the patient's body — and therefore the oxygen pressure they breathe — without changing the tent's actual elevation by a single meter.
This is the founding insight behind the portable hyperbaric bag: treat the physiology of altitude illness by simulating descent physically, using nothing more than a sealed flexible chamber and a hand or foot pump, entirely independent of weather, terrain, or helicopter availability.
The device that makes descent-simulation possible is deceptively simple: an airtight, puncture-resistant fabric cylinder just large enough for one person to lie down inside, sealed with a long zipper, and fitted with a one-way pressure-relief valve and a pump connector. It was invented in 1989 by Igor Gamow, a bioengineering researcher at the University of Wyoming — and son of the physicist George Gamow.
Igor Gamow developed the portable hyperbaric bag in 1989 while researching high-altitude physiology, adapting the concept of a hyperbaric chamber — long used in diving medicine to treat decompression sickness — into something light enough to carry on an expedition. The device carries his family name; his father, George Gamow, was a renowned theoretical physicist known for work on the Big Bang nucleosynthesis theory, though the bag itself is a pure application of respiratory and gas-law physiology rather than cosmology.
Wilderness medicine physician Bill Forgey was instrumental in popularizing the device through expedition medicine courses and his widely used wilderness medicine field guides, helping the Gamow bag become a standard item in the medical kits of guided high-altitude expeditions on peaks like Denali, Aconcagua, and in the Everest and Cho Oyu base camp regions by the 1990s.
Before the Gamow bag, the only way to raise ambient pressure around a hypoxic climber was a rigid hyperbaric chamber weighing hundreds of kilograms — completely impractical above base camp. A flexible fabric cylinder solved the weight problem and made hyperbaric therapy portable for the first time.
The bag itself is a coated nylon or urethane-fabric cylinder, roughly 2.1 m long and 0.7 m in diameter, reinforced along seams to resist the internal overpressure without bursting. A long zipper running the length of the bag allows the patient to be laid inside on an insulating pad, then sealed by an attendant from the outside. A small clear vinyl window lets rescuers monitor the patient's face and consciousness without opening the bag.
Two valves are essential: an inlet connector for the pump hose, and a one-way pressure-relief (dump) valve that vents air once a preset pressure is exceeded, preventing over-pressurization. Because the enclosure is fully sealed once zipped, an attendant must remain outside continuously — both to operate the pump and to monitor the patient, since verbal communication and physical access are both limited while the bag is sealed.
Before sealing, the team should confirm the patient can tolerate a fully enclosed space and lie flat, address any active vomiting risk (aspiration inside a sealed bag is dangerous — the airway must be manageable), and remove or loosen restrictive clothing since the bag will be warm and humid. Supplemental oxygen, if available, is typically prioritized over the bag when both exist, or combined with it, since oxygen requires no continuous pumping effort.
Once the patient is inside and the zipper closed, the bag is checked for a good seal by briefly pressurizing and listening/feeling for leaks at the zipper line and valve fittings — a real leak here can prevent the bag from ever reaching therapeutic pressure no matter how hard the pump is worked.
With the patient sealed inside, the treatment itself begins: a foot- or hand-operated pump forces ambient air into the fixed-volume enclosure. Because the bag's fabric walls do not stretch significantly, added air has nowhere to go — pressure inside the sealed volume rises above the pressure outside. This is Boyle's Law in its most direct field application.
Boyle's Law states that for a fixed amount of gas at constant temperature, pressure and volume are inversely related (P·V = constant). Inside the Gamow bag, the volume is essentially fixed by the fabric walls — so every additional stroke of the pump that forces more air molecules into that fixed volume raises the pressure of the gas already inside.
Critically, the patient's body does not need to move a single meter in elevation for this to work physiologically. What matters to the lungs is the partial pressure of oxygen in the air they breathe — and raising total ambient pressure while atmospheric oxygen fraction (~20.9%) stays constant proportionally raises the inspired PO2. A pressure increase inside the bag is, to the patient's alveoli, indistinguishable from having physically descended to a lower, thicker-air elevation.
A typical field target is about 2 psi (~140 mbar) of overpressure. Because atmospheric pressure declines roughly exponentially with altitude — more slowly at higher elevations — that same fixed 2 psi boost corresponds to a larger simulated descent when started from a higher camp: roughly 1500 m of equivalent descent from a 4500 m camp, but closer to 2000–2500 m of equivalent descent from a 6000–7000 m camp.
Unlike a rigid chamber that holds pressure passively, a fabric Gamow bag leaks slowly through the zipper, seams, and valve — pressure decays if pumping stops. In practice, an attendant must work the foot pump at a sustained pace (commonly cited at roughly 20 strokes per minute, adjusted to the specific bag and valve) to first build pressure over 5–15 minutes and then maintain it for the duration of treatment.
This is real physical labor at altitude — often performed by an already-exhausted teammate at 5000–7000 m, in the cold, for one to two hours at a stretch. Rescue teams often rotate pumping duty between members. The dump valve is set to release excess pressure automatically, so over-pumping beyond the target is self-limiting and cannot burst the bag under normal use.
A small analog pressure gauge, usually built into the pump hose fitting or bag wall, lets the attendant read bag overpressure directly in psi or mbar and confirm the target has been reached and held. Because the patient is sealed inside a semi-opaque enclosure, monitoring is otherwise limited to what can be seen through the small window and heard by voice — attendants typically ask the patient to respond verbally at intervals to confirm level of consciousness.
If pressure cannot be built or held despite steady pumping, the most common cause is a zipper or valve leak, and the team should re-check the seal rather than assume the pump itself has failed.
Once the bag holds therapeutic overpressure, the patient's physiology responds much as it would during a real descent of similar magnitude: inspired oxygen pressure rises, arterial oxygen saturation climbs, and the symptoms driven by hypoxia and edema — headache, ataxia, breathlessness — often begin to ease within one to two hours.
Inspired PO2 depends on total ambient pressure multiplied by the fraction of oxygen in air (essentially constant at 20.9%). Raising ambient pressure inside the bag by ~2 psi raises inspired PO2 by a proportional amount — pushing the patient back up the steep part of the oxyhemoglobin dissociation curve, where small PO2 gains translate into disproportionately large jumps in hemoglobin saturation.
This is why patients arriving in the bag with SpO2 in the 60s–70s can often be brought back into the 80s–90s within the first 30–60 minutes of effective pressurization — the same nonlinearity that makes altitude illness so dangerous in the first place (small PO2 losses causing large SpO2 drops) works in reverse as therapy.
Clinical field studies and case series — including early work by Bärtsch and colleagues on portable hyperbaric treatment for HAPE — reported measurable improvements in oxygen saturation, symptom scores, and pulmonary artery pressure after Gamow bag sessions, comparable in direction (though not necessarily magnitude) to supplemental oxygen or real descent.
For HAPE, rising ambient pressure reduces hypoxic pulmonary vasoconstriction, which lowers pulmonary artery pressure and reduces the capillary leak driving alveolar fluid accumulation — patients often report easier breathing and reduced cough within the first session, though radiographic edema resolves more slowly than symptoms.
For HACE, improved cerebral oxygenation can reduce the vasodilation and edema-driving cascade; ataxia and confusion often show partial improvement within a single 1–2 hour session, though severe cases with depressed consciousness need the most urgent evacuation regardless of bag response.
Importantly, response is not universal or guaranteed — a patient who fails to improve after an adequate pressurization session should be treated as a evacuation priority, not left in the bag hoping for delayed improvement.
The Gamow bag is most effective as one component of a combined field protocol rather than a stand-alone cure. Where available, supplemental oxygen is typically layered in before or alongside bag use since it requires no continuous pumping and directly raises inspired PO2 without needing an intact seal. Dexamethasone (for HACE) and nifedipine or PDE-5 inhibitors like tadalafil (for HAPE) act pharmacologically on the edema-driving mechanisms and can be given concurrently, since they don't require breaking the bag seal (oral medication can often be passed through before zipping, or via injection).
The combination of pressurization, oxygen, and medication buys the most time — but none of them, alone or together, replaces the requirement to descend as soon as it becomes physically possible.
A Gamow bag is bridge therapy, not definitive treatment. It is used in cycles — pressurized sessions punctuated by monitoring breaks — while the team waits for the conditions that make real descent possible again. Understanding its limitations is as important as understanding its physics, because over-reliance on the bag has contributed to preventable deaths when teams delayed evacuation too long.
Sessions are typically run for one to two hours, after which the patient is taken out of the bag (or the seal briefly broken) to reassess mental status, examine for other injuries, allow the attendant to rest from pumping, and decide whether conditions now allow descent. If symptoms remain severe or the patient cannot be moved, another pressurization cycle follows.
This cycling reflects both a practical limitation — sustained pumping is exhausting and attendants must rotate or rest — and a clinical one: symptoms can recur once pressurization stops, so a team cannot assume one session equals a cure and simply walk away.
Several practical constraints limit how the bag can be used in practice:
• Claustrophobia: being zipped into a narrow opaque cylinder is intensely distressing for some patients, and agitation can itself worsen a confused HACE patient's condition or cause them to fight the seal • No access to the patient while sealed: other injuries (fractures, frostbite, wounds) cannot be examined or treated without breaking the pressure seal, forcing a trade-off between hyperbaric therapy and other necessary care • Vomiting and aspiration risk: a sealed, reclined patient who vomits is at real risk of airway compromise before the bag can be opened • Continuous physical labor: someone must pump steadily for the entire session; in a small team this attendant cannot simultaneously help with other rescue tasks • No treatment for the underlying cause: the bag does not reverse the physiological trigger of altitude illness (it only offsets its effect), so relapse after the bag is opened is expected, not a treatment failure
These limitations are why the bag has always been framed in mountain medicine training as an evacuation-delay tool, not a substitute for evacuation.
Multiple wilderness medicine reviews and guideline bodies (including Wilderness Medical Society consensus guidelines) are explicit: the portable hyperbaric bag should never be used as a reason to delay descent when descent is actually possible. It exists specifically for the situations where descent is temporarily not an option.
While "Gamow bag" has become the generic field term (much like "Kleenex"), several other manufacturers produce functionally similar portable hyperbaric bags used on expeditions worldwide:
• Certec PAC (Portable Altitude Chamber) — a French-designed bag widely used by European and Himalayan guiding operations, functionally similar in construction and target pressure • CAT (Certec Altitude Chamber) — a related lightweight variant marketed for trekking and rescue teams • Various lighter expedition-specific variants have since been developed, trading some durability for reduced pack weight on ultralight climbs
All of these systems share the same underlying physics — a sealed flexible volume, a manual or battery pump, and a target overpressure in the same 1.5–2.5 psi range — differing mainly in fabric durability, valve design, packed weight, and price.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Real Descent | Lower actual elevation | Restores true ambient PO2; reverses hypoxic drive at its source | Only definitive, curative intervention |
| Gamow Bag (Portable Hyperbaric) | Simulated ~1500–2500 m descent | Raises ambient pressure in a sealed volume via manual pump (Boyle's Law) | Works when terrain/weather/darkness block real descent |
| Supplemental Oxygen | Raises inspired PO2 directly | Increases oxygen fraction of inspired gas via mask/cannula and cylinder | No continuous pumping; can combine with either bag or descent |
| Medication (Dexamethasone / Nifedipine) | No altitude change | Reduces cerebral (dexamethasone) or pulmonary (nifedipine) edema pharmacologically | Simple to administer, doesn't require any equipment |